Zusammenfassung
Strahlendermatitis (SD) ist eine entzündliche Hauterkrankung, die als ungewollte Nebenwirkung der medizinischen Strahlentherapie (ST) auftreten kann, am häufigsten bei Patienten, die im Rahmen einer Krebserkrankung der HNO- bzw. Anal- und Vulvaregion behandelt werden. Die Nebenwirkungen an der Haut und Schleimhaut treten innerhalb von wenigen Wochen nach der Einleitung von ST auf, späte Nebenwirkungen können sich Monate bis Jahre nach der ST entwickeln. Therapeutisch kommen verschiedene Behandlungsansätze in Betracht wie Pentoxifillin, hyperbare Sauerstofftherapie, Lasertherapie und Photobiomodulationstherapie (PBMT). Um die verminderte Lebensqualität von Patienten mit ST-induzierter Fibrose zu begrenzen, ist eine unterstützende Pflege aus Schmerztherapie, psychologischer Unterstützung und Wundversorgung notwendig.
Abstract
Radiation dermatitis (RD), an inflammatory skin disease that can be an unwanted side effect of medical radiation therapy (RT), most commonly occurs in patients undergoing cancer of the ENT, anal, and vulvar regions. The side effects on the skin and mucous membranes occur within a few weeks after the initiation of RT; however, late side effects can develop months to years after the RT. Therapeutically, various treatment approaches are considered such as pentoxifylline, hyperbaric oxygen therapy, laser therapy, and PBMT. In order to limit the reduced quality of life of patients with RT-induced fibrosis, supportive care consisting of pain therapy, psychological support, and wound care is necessary.
Literatur
Cancer Research UK (2012) Worldwide cancer statistics. http://www.cancerresearchuk.org/health-professional/cancer-statistics/worldwide-cancer. Zugegriffen: 25. Sept. 2017
The World Cancer Report—the major findings. Cent Eur J Public Health, 2003. 11(3):177–9
Balagamwala EH, Stockham A, Macklis R, Singh AD (2013) Introduction to radiotherapy and standard teletherapy techniques. Dev Ophthalmol 52:1–14
Cox J, Ang K (2010) Radiation oncology: rationale, technique, results, 9. Aufl. Elsevier Mosby, Amsterdam, Maryland Heights
Ryan JL (2012) Ionizing radiation: the good, the bad, and the ugly. J Invest Dermatol 132(3 Pt 2):985–993
Singh M, Alavi A, Wong R, Akita Radiodermatitis S (2016) A review of our current understanding. Am J Clin Dermatol 17(3):277–292
Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31(5):1341–1346
Fishbourne E, Ludi AB, Wilsden G et al (2017) Efficacy of a high potency O1 Manisa foot-and-mouth disease vaccine in cattle against heterologous challenge with a field virus from the O/ME-SA/Ind-2001 lineage collected in North Africa. Vaccine 35(20):2761–2765
Chen AP, Setser A, Anadkat MJ et al (2012) Grading dermatologic adverse events of cancer treatments: the common terminology criteria for adverse events version 4.0. J Am Acad Dermatol 67(5):1025–1039
Berthelet E, Truong PT, Musso K et al (2004) Preliminary reliability and validity testing of a new Skin Toxicity Assessment Tool (STAT) in breast cancer patients undergoing radiotherapy. Am J Clin Oncol 27(6):626–631
Schnur JB, Graff Zivin J, Mattson DM Jr. et al (2012) Acute skin toxicity-related, out-of-pocket expenses in patients with breast cancer treated with external beam radiotherapy: a descriptive, exploratory study. Support Care Cancer 20(12):3105–3113
Hymes SR, Strom EA, Fife C (2006) Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol 54(1):28–46
Spalek M (2016) Chronic radiation-induced dermatitis: challenges and solutions. Clin Cosmet Investig Dermatol 9:473–482
Harper JL, Franklin LE, Jenrette JM, Aguero EG (2004) Skin toxicity during breast irradiation: pathophysiology and management. South Med J 97(10):989–993
Yarnold J, Brotons MC (2010) Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol 97(1):149–161
Wells M, MacBride S (2003) Radiation skin reactions. Elsevier, Amsterdam
Mendelsohn FA, Divino CM, Reis ED, Kerstein MD (2002) Wound care after radiation therapy. Adv Skin Wound Care 15(5):216–224
Muller K, Meineke V (2007) Radiation-induced alterations in cytokine production by skin cells. Exp Hematol 35(4 Suppl 1):96–104
Denham JW, Hauer-Jensen M (2002) The radiotherapeutic injury—a complex ‘wound’. Radiother Oncol 63(2):129–145
Wong RK, Bensadoun RJ, Boers-Doets CB et al (2013) Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. Support Care Cancer 21(10):2933–2948
Lanigan SW, Joannides T (2003) Pulsed dye laser treatment of telangiectasia after radiotherapy for carcinoma of the breast. Br J Dermatol 148(1):77–79
Nymann P, Hedelund L, Haedersdal M (2009) Intense pulsed light vs. long-pulsed dye laser treatment of telangiectasia after radiotherapy for breast cancer: a randomized split-lesion trial of two different treatments. Br J Dermatol 160(6):1237–1241
Bourgeois JF, Gourgou S, Kramar A, Lagarde JM, Guillot B (2008) A randomized, prospective study using the LPG technique in treating radiation-induced skin fibrosis: clinical and profilometric analysis. Skin Res Technol 14(1):71–76
Jacobson G, Bhatia S, Smith BJ, Button AM, Bodeker K, Buatti J (2013) Randomized trial of pentoxifylline and vitamin E vs standard follow-up after breast irradiation to prevent breast fibrosis, evaluated by tissue compliance meter. Int J Radiat Oncol Biol Phys 85(3):604–608
Delanian S, Porcher R, Balla-Mekias S, Lefaix JL (2003) Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol 21(13):2545–2550
Delanian S, Porcher R, Rudant J, Lefaix JL (2005) Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol 23(34):8570–8579
Magnusson M, Hoglund P, Johansson K et al (2009) Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5). Eur J Cancer 45(14):2488–2495
Gothard L, Cornes P, Earl J et al (2004) Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer. Radiother Oncol 73(2):133–139
Deree J, Martins JO, Melbostad H, Loomis WH, Coimbra R (2008) Insights into the regulation of TNF-alpha production in human mononuclear cells: the effects of non-specific phosphodiesterase inhibition. Clinics (Sao Paulo) 63(3):321–328
Samlaska CP, Winfield EA (1994) Pentoxifylline. J Am Acad Dermatol 30(4):603–621
Marques LJ, Zheng L, Poulakis N, Guzman J, Costabel U (1999) Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages. Am J Respir Crit Care Med 159(2):508–511
Patel V, McGurk M (2017) Use of pentoxifylline and tocopherol in radiation-induced fibrosis and fibroatrophy. Br J Oral Maxillofac Surg 55(3):235–241
Pritchard J, Anand P, Broome J et al (2001) Double-blind randomized phase II study of hyperbaric oxygen in patients with radiation-induced brachial plexopathy. Radiother Oncol 58(3):279–286
Gothard L, Stanton A, MacLaren J et al (2004) Non-randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema and tissue fibrosis after radiotherapy for early breast cancer. Radiother Oncol 70(3):217–224
Teas J, Cunningham JE, Cone L et al (2004) Can hyperbaric oxygen therapy reduce breast cancer treatment-related lymphedema? A pilot study. J Womens Health (Larchmt) 13(9):1008–1018
Tran TN, Hoang MV, Phan QA et al (2015) Fractional epidermal grafting in combination with laser therapy as a novel approach in treating radiation dermatitis. Semin Cutan Med Surg 34(1):42–47
Veness M, Richards S (2012) Radiotherapy. In: Bolognia J, Jorizzo J, Schaffer J (Hrsg) Dermatology. Elsevier, New York
Schindl A, Schindl M, Schindl L, Jurecka W, Honigsmann H, Breier F (1999) Increased dermal angiogenesis after low-intensity laser therapy for a chronic radiation ulcer determined by a video measuring system. J Am Acad Dermatol 40(3):481–484
Schindl M, Kerschan K, Schindl A, Schon H, Heinzl H, Schindl L (1999) Induction of complete wound healing in recalcitrant ulcers by low-intensity laser irradiation depends on ulcer cause and size. Photodermatol Photoimmunol Photomed 15(1):18–21
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
H.-J. Laubach und J. Robijns geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Laubach, HJ., Robijns, J. Laser- und Lichttherapie zur Behandlung der Strahlendermatitis. Hautarzt 69, 5–9 (2018). https://doi.org/10.1007/s00105-017-4091-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-017-4091-4